PACS Group (NYSE:PACS) Earns Buy Rating from Analysts at Citigroup

Citigroup started coverage on shares of PACS Group (NYSE:PACS) in a report issued on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $32.00 target price on the stock.

Several other analysts have also recently weighed in on PACS. Oppenheimer initiated coverage on PACS Group in a research report on Monday. They set an outperform rating and a $31.00 price target for the company. Truist Financial started coverage on shares of PACS Group in a research report on Monday. They set a buy rating and a $32.00 target price for the company. Finally, Royal Bank of Canada began coverage on PACS Group in a report on Monday. They issued an outperform rating and a $30.00 price objective for the company. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, PACS Group presently has an average rating of Buy and a consensus target price of $30.50.

PACS Group Stock Down 1.3 %

Shares of PACS stock opened at $24.67 on Monday. PACS Group has a 52-week low of $22.61 and a 52-week high of $25.72.

Insiders Place Their Bets

In other news, CEO Jason Hulse Murray sold 1,607,142 shares of the stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the completion of the sale, the chief executive officer now directly owns 62,754,551 shares in the company, valued at $1,317,845,571. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.